Diphenylamine

Diphenylamine

SCHEMBL3065385

[LiH].c1ccc(Nc2ccccc2)cc1

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 5/20 0.92
▸ ALDH1A1 P00352 8/20 0.86
▸ TDP1 Q9NUW8 7/20 0.86
▸ TSHR P16473 5/20 0.86
▸ ALOX12 P18054 3/20 0.86
▸ L3MBTL1 Q9Y468 3/20 0.86
▸ ALOX15 P16050 2/20 0.86
▸ PTGS1 P23219 1/20 0.86
▸ SLC6A2 P23975 1/20 0.86
▸ MAPK1 P28482 1/20 0.86
▸ PTGS2 P35354 1/20 0.86
▸ HTR2B P41595 1/20 0.86
▸ MAPT P10636 7/20 0.71
▸ MEN1 O00255 5/20 0.71
▸ KMT2A Q03164 5/20 0.71
▸ AR P10275 1/20 0.71
▸ CYP3A4 P08684 5/20 0.63
▸ HPGD P15428 2/20 0.63
▸ HTT P42858 2/20 0.63
▸ CYP1A2 P05177 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylamine SCHEMBL301493 0.96 HSD17B10 (1.00) HSD17B10ALDH1A1TDP1TSHRALOX12
Diphenylamine SCHEMBL3003404 0.96 HSD17B10 (1.00) HSD17B10ALDH1A1TDP1TSHRALOX12
Diphenylamine SCHEMBL6828443 0.96 HSD17B10 (1.00) HSD17B10ALDH1A1TDP1TSHRALOX12
Diphenylamine SCHEMBL229 0.96 HSD17B10 (1.00) HSD17B10ALDH1A1TDP1TSHRALOX12
Diphenylamine SCHEMBL1619083 0.96 HSD17B10 (1.00) HSD17B10ALDH1A1TDP1TSHRALOX12
Diphenylamine SCHEMBL23295988 0.92 HSD17B10 (0.92) HSD17B10ALDH1A1TDP1TSHRALOX12
Diphenylamine SCHEMBL11684039 0.92 HSD17B10 (0.92) HSD17B10ALDH1A1TDP1TSHRALOX12
Diphenylamine SCHEMBL8602771 0.92 HSD17B10 (0.92) HSD17B10ALDH1A1TDP1TSHRALOX12
SCHEMBL7896372 0.92 ALDH1A1 (1.00) HSD17B10ALDH1A1TDP1TSHRALOX12
Diphenylamine SCHEMBL846236 0.92 HSD17B10 (0.92) HSD17B10ALDH1A1TDP1TSHRALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101279222-B Hydrogen storage reversible hydrogenated of pi-conjugated substrates AIR PROD & CHEM (US) 2012-02-15 — — CN claimed
CN-101279222-A Hydrogen storage reversible hydrogenated of pi-conjugated substrates AIR PROD & CHEM (US) 2008-10-08 — — CN claimed
CN-100381351-C Hydrogen storage by reversible hydrogenation of pi-conjugated substrates AIR PROD & CHEM (US) 2008-04-16 — — CN claimed
CN-1809505-A Hydrogen storage by reversible hydrogenation of pi-conjugated substrates AIR PROD & CHEM (US) 2006-07-26 — — CN claimed
CN-122036785-A IVB metal complex containing imidazoline (alkyl) -2-imino, catalyst system and method for preparing polymer by using IVB metal complex 东华大学 2026-05-15 — — CN disclosed
CN-114026132-A Carboxyl-terminated diene rubber 阿朗新科德国有限责任公司 2022-02-08 — — CN disclosed
CN-114026140-A 1-amino-3- (oxyalkylalkoxysilyl) -2-propanol-terminated diene rubber 阿朗新科德国有限责任公司 2022-02-08 — — CN disclosed
US-11224667-B2 11C-labeled catechol derivative, pet probe of phosphorylated tau aggregation inhibitor using the same, and production method of the same NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) 2022-01-18 — — US disclosed
US-20210205481-A1 11C-LABELED CATECHOL DERIVATIVE, PET PROBE OF PHOSPHORYLATED TAU AGGREGATION INHIBITOR USING THE SAME, AND PRODUCTION METHOD OF THE SAME NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) 2021-07-08 — — US disclosed
EP-3482775-A1 11C-LABELLED CATECHOL DERIVATIVE, POSITRON EMISSION TOMOGRAPHY (PET) PROBE FOR PHOSPHORYLATED TAU AGGREGATION INHIBITOR USING SAME, AND PRODUCTION METHODS THEREFOR National Center for Geriatrics and Gerontology (JP) 2019-05-15 — — EP disclosed
CN-109414513-A 11C-labeled catechol derivative, PET probe for phosphorylated tau aggregation inhibitor using 11C-labeled catechol derivative, and method for producing same 国立研究开发法人国立长寿医疗研究中心 2019-03-01 — — CN disclosed
CN-108285442-A A kind of organic semiconductor laser material and the preparation method and application thereof 南京邮电大学 2018-07-17 — — CN disclosed
CN-101279222-B Hydrogen storage reversible hydrogenated of pi-conjugated substrates AIR PROD & CHEM (US) 2012-02-15 — — CN disclosed
US-20100258790-A1 USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS BASF SE (DE) 2010-10-14 — — US disclosed
CN-101279222-A Hydrogen storage reversible hydrogenated of pi-conjugated substrates AIR PROD & CHEM (US) 2008-10-08 — — CN disclosed
CN-100381351-C Hydrogen storage by reversible hydrogenation of pi-conjugated substrates AIR PROD & CHEM (US) 2008-04-16 — — CN disclosed
CN-1809505-A Hydrogen storage by reversible hydrogenation of pi-conjugated substrates AIR PROD & CHEM (US) 2006-07-26 — — CN disclosed
US-6022835-A Lubricating composition SHELL OIL COMPANY (US) 2000-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210205481-A1 11C-LABELED CATECHOL DERIVATIVE, PET PROBE OF PHOSPHORYLATED TAU AGGREGATION INHIBITOR USING THE SAME, AND PRODUCTION METHOD OF THE SAME MAPT, APP, PSEN1 HSD17B10 2231/4885ALDH1A1 1788/4885TDP1 305/4885
US-11224667-B2 11C-labeled catechol derivative, pet probe of phosphorylated tau aggregation inhibitor using the same, and production method of the same MAPT, APP, PSEN1 HSD17B10 2231/4885ALDH1A1 1788/4885TDP1 305/4885
US-20100258790-A1 USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS TRPC6, KCNB1, CACNA1I HSD17B10 4012/4885ALDH1A1 2842/4885TDP1 3032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback